- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 702848, 11 pages
Meconium Indicators of Maternal Alcohol Abuse during Pregnancy and Association with Patient Characteristics
1Department of Obstetrics and Gynecology, Friedrich-Alexander-University of Erlangen-Nuremberg, Universitaetsstraß 21-23, 91054 Erlangen, Germany
2Department of Obstetrics and Gynecology, University of RWTH Aachen, Pauwelsstrß 30, 52074 Aachen, Germany
3Department of Psychiatry and Psychotherapy, Friedrich-Alexander-University of Erlangen-Nuremberg, Schwabachanlage 6-10, 91054 Erlangen, Germany
4Institute of Legal Medicine, University Hospital Charité, Hittorfstraße 18, 14195 Berlin, Germany
5Lipidomix GmbH, Berliner Allee 261-269, 13088 Berlin, Germany
Received 12 January 2014; Revised 12 February 2014; Accepted 12 February 2014; Published 30 March 2014
Academic Editor: Gottfried E. Konecny
Copyright © 2014 Tamme W. Goecke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. Derauf, A. R. Katz, and D. Easa, “Agreement between maternal self-reported ethanol intake and tobacco use during pregnancy and meconium assays for fatty acid ethyl esters and cotinine,” American Journal of Epidemiology, vol. 158, no. 7, pp. 705–709, 2003.
- F. M. Wurst, E. Kelso, W. Weinmann, F. Pragst, M. Yegles, and I. Sundström Poromaa, “Measurement of direct ethanol metabolites suggests higher rate of alcohol use among pregnant women than found with the AUDIT-a pilot study in a population-based sample of Swedish women,” American Journal of Obstetrics and Gynecology, vol. 198, no. 4, pp. 407.e1–407.e5, 2008.
- N. Raymond, C. Beer, C. Glazebrook, and K. Sayal, “Pregnant women's attitudes towards alcohol consumption,” BMC Public Health, vol. 9, article 175, 2009.
- P. A. Fried, C. M. O'Connell, and B. Watkinson, “60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment,” Journal of Developmental and Behavioral Pediatrics, vol. 13, no. 6, pp. 383–391, 1992.
- A. C. Huizink and E. J. H. Mulder, “Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring,” Neuroscience and Biobehavioral Reviews, vol. 30, no. 1, pp. 24–41, 2006.
- M. Robert, A. Carceller, V. Domken, et al., “Physical and neurodevelopmental evaluation of children adopted from Eastern Europe,” Canadian Journal of Clinical Pharmacology, vol. 16, no. 3, pp. e432–e440, 2009.
- U. Kesmodel, K. Wisborg, S. F. Olsen, T. B. Henriksen, and N. J. Secher, “Moderate alcohol intake during pregnancy and the risk of stillbirth and death in the first year of life,” American Journal of Epidemiology, vol. 155, no. 4, pp. 305–312, 2002.
- C. M. O'Leary, N. Nassar, J. J. Kurinczuk et al., “Prenatal alcohol exposure and risk of birth defects,” Pediatrics, vol. 126, no. 4, pp. e843–e850, 2010.
- M. L. Martínez-Frías, E. Bermejo, E. Rodríguez-Pinilla, and J. L. Frías, “Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case-control study,” Birth Defects Research A, vol. 70, no. 4, pp. 194–200, 2004.
- M. Todorow, T. E. Moore, and G. Koren, “Investigating the effects of low to moderate levels of prenatal alcohol exposure on child behaviour: a critical review,” Journal of Population Therapeutics and Clinical Pharmacology, vol. 17, no. 2, pp. e323–e330, 2010.
- A. M. Dunning, C. S. Healey, C. Baynes, et al., “Association of ESR1 gene tagging SNPs with breast cancer risk,” Human Molecular Genetics, vol. 18, no. 6, pp. 1131–1139, 2009.
- M. Robinson, W. H. Oddy, N. J. McLean et al., “Low-moderate prenatal alcohol exposure and risk to child behavioural development: a prospective cohort study,” British Journal of Obstetrics and Gynaecology, vol. 117, no. 9, pp. 1139–1150, 2010.
- Y. J. Kelly, A. Sacker, R. Gray et al., “Light drinking during pregnancy: still no increased risk for socioemotional difficulties or cognitive deficits at 5 years of age?” Journal of Epidemiology and Community Health, vol. 66, no. 1, pp. 41–48, 2012.
- Y. Kelly, A. Sacker, R. Gray, J. Kelly, D. Wolke, and M. A. Quigley, “Light drinking in pregnancy, a risk for behavioural problems and cognitive deficits at 3 years of age?” International Journal of Epidemiology, vol. 38, no. 1, pp. 129–140, 2009.
- V. Gijsen, N. Fulga, F. Garcia-Bournissen, and G. Koren, “Does light drinking during pregnancy improve pregnancy outcome? A critical commentary,” The Canadian Journal of Clinical Pharmacology, vol. 15, no. 3, pp. e782–e786, 2008.
- N. Kenan, A. Larsson, O. Axelsson, and A. Helander, “Changes in transferrin glycosylation during pregnancy may lead to false-positive carbohydrate-deficient transferrin (CDT) results in testing for riskful alcohol consumption,” Clinica Chimica Acta, vol. 412, no. 1-2, pp. 129–133, 2011.
- J. D. Cook, “Biochemical markers of alcohol use in pregnant women,” Clinical Biochemistry, vol. 36, no. 1, pp. 9–19, 2003.
- N. de Giovanni, G. Donadio, and M. Chiarotti, “The reliability of Fatty Acid Ethyl Esters (FAEE) as biological markers for the diagnosis of alcohol abuse,” Journal of Analytical Toxicology, vol. 31, no. 2, pp. 93–97, 2007.
- D. L. Caprara, J. Klein, and G. Koren, “Diagnosis of fetal alcohol spectrum disorder (FASD): fatty acid ethyl esters and neonatal hair analysis,” Annali dell'Istituto Superiore di Sanita, vol. 42, no. 1, pp. 39–45, 2006.
- A. Bakdash, P. Burger, T. W. Goecke et al., “Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study,” Analytical and Bioanalytical Chemistry, vol. 396, no. 7, pp. 2469–2477, 2010.
- F. Pragst, M. Rothe, B. Moench, M. Hastedt, S. Herre, and D. Simmert, “Combined use of fatty acid ethyl esters and ethyl glucuronide in hair for diagnosis of alcohol abuse: interpretation and advantages,” Forensic Science International, vol. 196, no. 1–3, pp. 101–110, 2010.
- L. Morini, E. Marchei, F. Vagnarelli et al., “Ethyl glucuronide and ethyl sulfate in meconium and hair-potential biomarkers of intrauterine exposure to ethanol,” Forensic Science International, vol. 196, no. 1–3, pp. 74–77, 2010.
- J. R. Hutson, K. Aleksa, F. Pragst, and G. Koren, “Detection and quantification of fatty acid ethyl esters in meconium by headspace-solid-phase microextraction and gas chromatography-mass spectrometry,” Journal of Chromatography B, vol. 877, no. 1-2, pp. 8–12, 2009.
- U. Reulbach, S. Bleich, J. Knörr et al., “Pre-, peri- and postpartal depression first cognition from FRAMES (Franconian Maternal Health Evaluation Studies),” Fortschritte der Neurologie Psychiatrie, vol. 77, no. 12, pp. 708–713, 2009.
- D. Mehta, C. Quast, P. A. Fasching et al., “The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms,” Journal of Affective Disorders, vol. 136, no. 3, pp. 1192–1197, 2012.
- P. A. Fasching, F. Faschingbauer, T. W. Goecke, et al., “Genetic variants in the tryptophan hydroxylase 2 gene (TPH2) and depression during and after pregnancy,” Journal of Psychiatric Research, vol. 46, no. 9, pp. 1109–1117, 2012.
- A. Hein, C. Rauh, A. Engel, et al., “Socioeconomic status and depression during and after pregnancy in the Franconian Maternal Health Evaluation Studies (FRAMES),” Archives of Gynecology and Obstetrics, 2013.
- F. Pragst, V. Auwaerter, F. Sporkert, and K. Spiegel, “Analysis of fatty acid ethyl esters in hair as possible markers of chronically elevated alcohol consumption by headspace solid-phase microextraction (HS-SPME) and gas chromatography-mass spectrometry (GC-MS),” Forensic Science International, vol. 121, no. 1-2, pp. 76–88, 2001.
- V. Kulaga, Y. Velazquez-Armenta, K. Aleksa, Z. Vergee, and G. Koren, “Assessment and detection: the effect of hair pigment on the incorporation of fatty acid ethyl esters (FAEE),” Alcohol and Alcoholism, vol. 44, no. 3, pp. 287–292, 2009.
- A. Thierauf, H. Gnann, A. Wohlfarth et al., “Urine tested positive for ethyl glucuronide and ethyl sulphate after the consumption of “non-alcoholic” beer,” Forensic Science International, vol. 202, no. 1–3, pp. 82–85, 2010.
- A. Thierauf, C. C. Halter, S. Rana et al., “Urine tested positive for ethyl glucuronide after trace amounts of ethanol,” Addiction, vol. 104, no. 12, pp. 2007–2012, 2009.
- A. Thierauf, A. Wohlfarth, V. Auwärter, M. G. Perdekamp, F. M. Wurst, and W. Weinmann, “Urine tested positive for ethyl glucuronide and ethyl sulfate after the consumption of yeast and sugar,” Forensic Science International, vol. 202, no. 1–3, pp. e45–e47, 2010.
- A. E. Gifford, K. J. Farkas, L. W. Jackson et al., “Assessment of benefits of a universal screen for maternal alcohol use during pregnancy,” Birth Defects Research A, vol. 88, no. 10, pp. 838–846, 2010.
- D. Chan, J. Klein, T. Karaskov, and G. Koren, “Fetal exposure to alcohol as evidenced by fatty acid ethyl esters in meconium in the absence of maternal drinking history in pregnancy,” Therapeutic Drug Monitoring, vol. 26, no. 5, pp. 474–481, 2004.
- L. Burd and R. Hofer, “Biomarkers for detection of prenatal alcohol exposure: a critical review of fatty acid ethyl esters in meconium,” Birth Defects Research A, vol. 82, no. 7, pp. 487–493, 2008.
- F. Pragst and M. Yegles, “Determination of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in hair: a promising way for retrospective detection of alcohol abuse during pregnancy?” Therapeutic Drug Monitoring, vol. 30, no. 2, pp. 255–263, 2008.
- S. Pichini, L. Morini, E. Marchei et al., “Ethylglucuronide and ethylsulfate in meconium to assess gestational ethanol exposure: preliminary results in two Mediterranean cohorts,” The Canadian Journal of Clinical Pharmacology, vol. 16, no. 2, pp. e370–e375, 2009.
- L. Morini, A. Groppi, E. Marchei et al., “Population baseline of meconium ethyl glucuronide and ethyl sulfate concentrations in newborns of nondrinking women in 2 Mediterranean cohorts,” Therapeutic Drug Monitoring, vol. 32, no. 3, pp. 359–363, 2010.
- S. Süße, C. M. Selavka, T. Mieczkowski, and F. Pragst, “Fatty acid ethyl ester concentrations in hair and self-reported alcohol consumption in 644 cases from different origin,” Forensic Science International, vol. 196, no. 1–3, pp. 111–117, 2010.
- C. Moore, J. Jones, D. Lewis, and K. Buchi, “Prevalence of fatty acid ethyl esters in meconium specimens,” Clinical Chemistry, vol. 49, no. 1, pp. 133–136, 2003.
- Y. I. Goh, J. R. Hutson, L. Lum et al., “Rates of fetal alcohol exposure among newborns in a high-risk obstetric unit,” Alcohol, vol. 44, no. 7-8, pp. 629–634, 2010.
- B. Yazdi, H. Abele, E. M. Grischke, et al., “Obstetrics. Prenatal care in reconstruction: from head to toe?” Geburtsh Frauenheilk, vol. 73, no. 4, pp. 295–298, 2013.
- P. Bühring, “Fetales Alkoholsyndrom: zu hundert Prozent vermeidbar,” Deutsches Ärzteblatt, vol. 105, no. 43, pp. A-2258/B-1931/C-1879, 2008.
- T. Besier, M. Pillhofer, S. Botzenhart, et al., “Child abuse and neglect: screening for risks during the perinatal period,” Geburtsh Frauenheilk, vol. 72, no. 5, pp. 397–402, 2012.
- W. Schwab, C. Marth, and A. M. Bergant, “Post-traumatic stress disorder post partum: the impact of birth on the prevalence of post-traumatic stress disorder (PTSD) in multiparous women,” Geburtshilfe und Frauenheilkunde, vol. 72, no. 1, pp. 56–63, 2012.